29/05/2025 - Research

A new GCAT study improves the population representativeness of the cohort to advance translational research in public health

IGTP’s strategic project GCAT|Genomes for Life has published a study in the journal Scientific Reports proposing a method to correct selection biases in population-based cohorts. The study represents a significant step forward in improving the reliability of data derived from such studies for public health research and precision medicine.

22/05/2025 - Projects, Research, Success Stories

FOXP4 gene identified in the first large-scale genetic study on Long COVID with participation of the GCAT

New insights into the complexities of Long COVID have been brought to light, thanks to an international collaborative effort with the participation of researchers from GCAT|Genomes for life, a strategic project of IGTP. A study published today in Nature Genetics used the vast data from the COVID-19 Host Genetics Initiative to perform the first study examining the entire genetic code specifically focused on Long COVID.

14/03/2025 - Projects, Research

Symptoms of long-COVID can last up to two years after infection with COVID-19

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID.

21/11/2024 - Projects, Research

GCAT joins the CORDELIA consortium to create the largest cardiovascular genetic study in southern Europe

The participation of the GCAT|Genomes For Life cohort in the CORDELIA consortium represents a strategic step to enhance and expand the impact of population research on the IGTP campus. This collaboration is part of the transversal CORE program, aimed at fostering innovative and translational research, implementing new knowledge in clinical practice, and improving population health.

04/11/2024 - Campus Can Ruti, Conferences, Institutional

IGTP and EATRIS strengthen ties with a symposium focused on driving translational research with patient involvement

IGTP has held an event to share resources, perspectives, and advancements as a centre linked to EATRIS, with a special focus on patient involvement in biomedical research.

29/10/2024 - Research

Discovery of a potential molecular mechanism to reduce cardiovascular risk in 6 genetic regions through the metabolites they regulate

Researchers from five Catalan research centres have collaborated on a large-scale genetic study, identifying genetic loci and therapeutic targets that could reduce cardiovascular risk by modulating blood metabolites.

30/09/2024 - Campus Can Ruti, Outreach, Success Stories

Notable presence of IGTP researchers at European Researchers' Night

Several researchers from IGTP took part in this year's European Researchers' Night in Barcelona. They shared their passion for science through talks and led participants of a workshop via a board game into the midst of a tuberculosis epidemic.

19/06/2024 - Projects, Research

Decoding depression amidst COVID-19: a comprehensive analysis of genetic and environmental stressors by GCAT

As a strategic initiative under IGTP, GCAT (Genomes for Life) continues to make substantial contributions to public health knowledge. The latest GCAT study, conducted through the COVICAT initiative, signed by Ximena Goldberg and Rafael de Cid, sheds light on the complex interplay between genetic predispositions and environmental stressors in determining depression risk, especially during the COVID-19 lockdown. Published in Scientific Reports.

23/02/2024 - Conferences, Outreach, Success Stories

Thirteen researchers from IGTP bring science closer to students in the 6th edition of #100tífiques

On 7 February, "#100tífiques" returned for its sixth edition, a macro-event that has become a benchmark for advocacy within the Catalan female research community and schools. Expanding on last year's participant numbers, thirteen scientists from IGTP took part in this event.

06/02/2024 - Research

Alterations in the blood immune system found to increase cancer risk

An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood. This is a significant advance in the understanding of how the immune system can prevent the appearance of tumours.